| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.9 |